PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy
Tóm tắt
The skin is an important barrier against environmental allergens, but infants have relatively impaired skin barrier function. There is evidence that impaired skin barrier function increases the risk of allergic sensitisation, atopic dermatitis (AD) and food allergy. We hypothesise that regular prophylactic use of emollients, particularly those that are designed to improve skin barrier structure and function, will help prevent these conditions. With the aim of determining if application of a ceramide-dominant emollient two times per day reduces the risk of AD and food allergy, we have commenced a multicentre phase III, outcome assessor blinded, randomised controlled trial of this emollient applied from birth to 6 months.
Infants (n=760) with a family history of allergic disease will be recruited from maternity hospitals in Melbourne. The primary outcomes are as follows: the presence of AD, assessed using the UK Working Party criteria, and food allergy using food challenge, in the first 12 months of life as assessed by a blinded study outcome assessor. Secondary outcomes are as follows: food sensitisation (skin prick test), skin barrier function, AD severity, the presence of new onset AD after treatment cessation (between 6 and 12 months) and the presence of parent reported AD/eczema. Recruitment commenced in March 2018.
The PEBBLES Study is approved by the Human Research Ethics Committees of the Royal Children’s Hospital (RCH) (#37090A) and the Mercy Hospital for Women (2018–008). Parents or guardians will provide written informed consent. Outcomes will be disseminated through peer-reviewed publications and presented at scientific conferences.
ACTRN12617001380381 and
Từ khóa
Tài liệu tham khảo
Khan, 2018, Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data, Allergy, 73, 17, 10.1111/all.13228
Kelleher, 2015, Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year, J Allergy Clin Immunol, 135, 930, 10.1016/j.jaci.2014.12.013
Lowe, 2018, A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study, Br J Dermatol, 178, e19, 10.1111/bjd.15747
Lowe, 2018, The skin as a target for prevention of the atopic march, Ann Allergy Asthma Immunol, 120, 145, 10.1016/j.anai.2017.11.023
Sugarman, 2009, Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis, J Drugs Dermatol, 8, 1106
Simpson, 2012, How should an incident case of atopic dermatitis be defined? A systematic review of primary prevention studies, J Allergy Clin Immunol, 130, 137, 10.1016/j.jaci.2012.01.075
Kim, 2016, Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy, J Allergy Clin Immunol, 137, 1282, 10.1016/j.jaci.2015.12.1306
Chng, 2016, Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare, Nat Microbiol, 1, 16106, 10.1038/nmicrobiol.2016.106
Glatz, 2018, Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis, PLoS One, 13, 10.1371/journal.pone.0192443
Pawankar R , Canonica GW , Holgate ST , et al . The WAO White Book on Allergy. 2013.
Abramson MJ , Puy RM , Weiner JM . Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010:CD001186.doi:10.1002/14651858.CD001186.pub2
Foisy, 2011, Overview of reviews the prevention of eczema in infants and children: an overview of cochrane and non-cochrane reviews, Evid Based Child Health, 6, 1322, 10.1002/ebch.827
Lodge, 2013, Overview of evidence in prevention and aetiology of food allergy: a review of systematic reviews, Int J Environ Res Public Health, 10, 5781, 10.3390/ijerph10115781
Ashley, 2017, The skin barrier function gene SPINK5 is associated with challenge-proven IgE-mediated food allergy in infants, Allergy, 72, 1356, 10.1111/all.13143
Silverberg, 2017, What’s in a name? Atopic dermatitis or atopic eczema, but not eczema alone, Allergy, 72, 2026, 10.1111/all.13225
Martin, 2013, The prevalence and socio-demographic risk factors of clinical eczema in infancy: a population-based observational study, Clin Exp Allergy, 43, 642, 10.1111/cea.12092